SCHEMBL16655557

SCHEMBL16655557

NC1COC(c2nc3ccc(Cl)cc3s2)C1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.43
▸ RAB9A P51151 7/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ MAPT P10636 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CLK1 P49759 1/20 0.40
▸ CASP3 P42574 2/20 0.40
▸ SENP8 Q96LD8 2/20 0.40
▸ SENP7 Q9BQF6 2/20 0.40
▸ SENP6 Q9GZR1 2/20 0.40
▸ P2RY2 P41231 1/20 0.39
▸ APP P05067 1/20 0.39
▸ ROCK2 O75116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30731280 0.75 NPC1 (0.47) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL30731277 0.69 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL334252 0.69 NPC1 (0.61) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL6888209 0.68 P2RY2 (0.53) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL6888217 0.68 P2RY2 (0.53) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29040239 0.68 CASP3 (0.41) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL8314254 0.67 NPC1 (0.77) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL16666139 0.67 HCRTR1 (0.56) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL6395255 0.67 P2RY2 (0.62) SMN1; SMN2MAPTKDM4ELMNAP2RY2
SCHEMBL17958701 0.67 HCRTR1 (0.56) NPC1RAB9ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057957-A1 CYCLOPENTYLBENZAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PSYCHOTIC AND COGNITIVE DISORDERS Takeda Pharmaceutical Company Limited (JP) 2016-08-24 — — EP disclosed
WO-2015055994-A1 CYCLOPENTYLBENZAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PSYCHOTIC AND COGNITIVE DISORDERS TAKEDA CAMBRIDGE LIMITED (GB) 2015-04-23 — — WO disclosed
Send feedback